Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(5S,14S,17S,20S,23S,26S,29S,35S,38S,41S,44S,47S)-26-((1H-imidazol-5-yl)methyl)-1-amino-5,14-bis(2-amino-2-oxoethyl)-47-(2-((S)-2-amino-3-(1H-indol-3-yl)propanamido)acetamido)-41-benzyl-23-(3-guanidinopropyl)-38-(hydroxymethyl)-20-isobutyl-29-isopropyl-17,35,44-trimethyl-1,4,7,10,13,16,19,22,25,28,31,34,37,40,43,46-hexadecaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45-pentadecaazapentacontan-50-oic acid
ID: ALA4787098
Chembl Id: CHEMBL4787098
PubChem CID: 162667824
Max Phase: Preclinical
Molecular Formula: C78H115N27O23
Molecular Weight: 1798.94
Molecule Type: Unknown
Associated Items: